secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2025-08-01T23:59:59+00:00
Accession:  0001437749-25-024411
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech furnishes July 2025 corporate presentation; no specific financial data extractable
--------------------------------------------------------------------------------

- Presentation posted on company website under Item 7.01 FD Disclosure.
- Exhibit 99.1 is an image-based presentation; textual content not provided.
- No new financial or operational figures available from the filing.
- Routine disclosure; no material changes reported in the body of the 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925024411/0001437749-25-024411-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925024411/mbrx20250731_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-024411

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer